Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2001
10/16/2001US6303790 Process for the preparation of pyridine derivatives
10/16/2001US6303789 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
10/16/2001US6303788 Process for preparing omeprzole
10/16/2001US6303778 Fractionated polydisperse compositions
10/16/2001US6303774 Antiviral agents, anticancer agents, metabolic moderators
10/16/2001US6303771 Pth
10/16/2001US6303755 Therapeutic multispecific compounds comprised of anti-FCA receptor antibodies
10/16/2001US6303661 Orally administering inhibitor of dipeptidyl peptidase (dp iv) or of dipeptidyl peptidase iv-like activity
10/16/2001US6303660 Enhanced anti-cancer agent delivery to solid tumors by primer compounds
10/16/2001US6303659 Administering adamantane derivative for therapy of rheumatoid arthritis
10/16/2001US6303658 Therapy of ocular hypertension by applying cyclopentane heptenoic acid or heptanoic acid and/or derivative
10/16/2001US6303656 For therapy and/or prophylaxis of human skin, mucous membranes and/or keratin fibers, in particular for moisturizing the skin and for treatment of dry skin
10/16/2001US6303655 Administering n-(3,4-dimethoxycinnamoyl)anthranilic acid or its salt for therapy of diseases associated with excessive proliferation of retinal pigment epithilial cells
10/16/2001US6303654 Exposing tumor cells to farnesyl anthranilate and carrier to inhibit or reduce tumor cell growth
10/16/2001US6303653 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
10/16/2001US6303652 BTK inhibitors and methods for their identification and use
10/16/2001US6303650 Aminoindan derivatives
10/16/2001US6303649 Naphthalene derivatives
10/16/2001US6303648 Methods and compositions for the treatment and prevention of lung disease
10/16/2001US6303647 Plantago majorand piper methysticum compound for use in treating a tobacco or nicotine habit
10/16/2001US6303646 Administering drug targeted to protein kinase c .alpha. enzyme to determine state of cancer for therapy of breast cancer leukemia, lung cancer, bone cancer, skin cancer, prostate cancer, melanoma, pancreatic cancer
10/16/2001US6303645 Benzimidazole derivatives as modulators of IgE
10/16/2001US6303644 Administering proton pump inhibitor or its salt in comination with antibacterial compound for therapy of bacterial disease which does not effect gastrointestinal tract
10/16/2001US6303643 Therapy of migraine headache, hypertension, alcohol withdrawal, drug addiction, rheumatoid arthritis, presbyopia, ischemic pain, spasticity, diarrhea, nasal congestion, and urinary incontinence by administering benzothiazole derivative
10/16/2001US6303642 Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid as a mucolytic agents
10/16/2001US6303641 Cyanoamidines as cell proliferation inhibitors
10/16/2001US6303640 Administering oxazole or thiazole derivative compound for reducing side effects of diabetic therapy
10/16/2001US6303639 Propanolamine derivatives substituted by heterocyclic radicals, processes for their preparation, pharmaceuticals comprising these compounds and their use
10/16/2001US6303637 For therapy of autoimmune disease, prophylaxis of resistance to transplantation or transplantation rejection of organs or tissues; suppressing immune system
10/16/2001US6303636 Arylsulfonylamino hydroxamic acid derivatives
10/16/2001US6303635 Thrombolytic drug
10/16/2001US6303634 Therapy and prophylaxis of breast cancer in a human by administering to human benzothiophene derivative
10/16/2001US6303633 Heteroaryl amines as novel acetylcholinesterase inhibitors
10/16/2001US6303632 Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients
10/16/2001US6303631 Water-soluble eye drop
10/16/2001US6303629 Methods for treating inflammation, inflammatory diseases, arthritis and stroke using pADPRT inhibitors
10/16/2001US6303628 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents
10/16/2001US6303627 For therapy of physiological and psychological disorders
10/16/2001US6303626 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound
10/16/2001US6303625 Triazolopyridines for the treatment of thrombosis disorders
10/16/2001US6303623 Bicycloloactam compounds, use thereof and intermediates for preparing thereof
10/16/2001US6303619 Meta-substituted acidic 8-phenylxanthine antagonists of A3 human adenosine receptors
10/16/2001US6303618 Cyclin dependent kinase inhibiting purine derivatives
10/16/2001US6303615 2,3 disubstituded-4(3H)-quinazolinones
10/16/2001US6303614 Tetrahydro gamma-carbolines
10/16/2001US6303613 As nitric oxide synthase inhibitor useful in therapy or prophylaxis of inflammatory disease and pain
10/16/2001US6303612 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxphenylsulfanylarylacetic acids
10/16/2001US6303611 For therapy of hyperalgesis
10/16/2001US6303610 Method of treating gout with certain indole compounds
10/16/2001US6303608 2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use
10/16/2001US6303607 Administering sustained release pharmaceutical dosage form including ranolazine, ph-dependent and ph-independent binders to human suffering from variant or excercise-induced angina
10/16/2001US6303606 Use of selective antagonists of the α1B-adrenergic receptor for improvement of sexual dysfunction
10/16/2001US6303605 For therapy of anxiety and convulsions
10/16/2001US6303604 Pharmaceutical composition comprising 2,4-diamino-6-benzyloxy-s-triazine and inactivation of O6-alkylguanine-DNA-alkyltransferase
10/16/2001US6303603 3-oxo-2(H)-1,2,4-triazine derivatives as ligands of 5 HT1A receptors
10/16/2001US6303602 Useful as analgesic, anesthetic, anti-inflammatory or neuroprotective agent, or for therapy of arthritis, stroke of functional bowel disease
10/16/2001US6303601 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
10/16/2001US6303600 Substituted azabicyclic compounds
10/16/2001US6303597 For therapy of anxiety and convulsions
10/16/2001US6303596 Administering effective amount of taurolidine to render leukemia-causing cells apoptotic
10/16/2001US6303595 Use of mirtazapine for treating sleep apneas
10/16/2001US6303593 For therapy human immunodeficiency virus infection, aquired immunodeficiency syndrome (aids), inflammatory and immunoregulatory disorder or disease, asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis
10/16/2001US6303592 7-alkylidene cephalosporanic acid derivatives and methods of using the same
10/16/2001US6303591 For therapy of cushing's syndrome or depression
10/16/2001US6303582 Compositions and methods for nucleic acid delivery to the lung
10/16/2001US6303581 Methods and kits for removing, treating, or preventing lice with driable pedicul ostatic agents
10/16/2001US6303579 Use of calpain inhibitors to treat ocular neural pathology
10/16/2001US6303577 Use of a peptide compound in the treatment of systemic lupus erythematosus
10/16/2001US6303569 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
10/16/2001US6303376 Stimulation using cellular dna synthesis or repair mechanisms
10/16/2001US6303374 By hybridization with nucleic acid; controlling apoptosis and programmed cell death; alzheimer*s, parkinson*s, autoimmune, and viral diseases; cancer; amyotrophic lateral sclerosis
10/16/2001US6303347 Vaccines
10/16/2001US6303342 Recombinant methods and materials for producing epothilones C and D
10/16/2001US6303334 Nucleotide sequences coding polypeptides for use in as a viricide and in gene therapy
10/16/2001US6303333 Expression vector which codes polypeptides for the diagnosis and treatment of cancer, dietetics, inflammation, cardiovascular disorders, crohn's diseases, neuropathies and immune defects
10/16/2001US6303321 Methods for diagnosing sepsis
10/16/2001US6303319 Cell based assay for identifying sh2-domain-specific signal transducer antagonist
10/16/2001US6303312 Modifying cell phenotype; medical research and therapy
10/16/2001US6303167 Mixing silica and liquid mixed tocopherol to produce dry free-flowing powders
10/16/2001US6303157 Extracts of kava-kava
10/16/2001US6303146 Solid oral dosage form comprising a combination of metformin and glibenclamide
10/16/2001US6303145 Administering (s,r)-formoterol, or a pharmaceutically acceptable salt thereof, said (s,r)-formoterol for inducing bronchodialation, relieving or preventing brohchospasm
10/16/2001US6303142 Administering sustained release analgesic formulation; applying apparatus capable of generating controlled heat by exposing oxygen activated exothermic medium; heating skin portion
10/16/2001US6303141 Passive sustained release transdermal drug delivery system
10/16/2001US6303139 Dietary product effective to combat oxidative stress and cell decay
10/16/2001US6303135 Use of quinolines and quinolones to treat male erectile dysfunction
10/16/2001US6303132 Administering progesterone using EMU oil
10/16/2001US6303125 Anti-microbial-adhesion fraction derived from vaccinium
10/16/2001US6303120 Inducing antibodies in a subject to an allyl-substituted pentasaccharide by administering the compound conjugated to a protein carrier at its allyl group.
10/16/2001US6303103 1,1,1,2-tetrafluoroethane as propellant; inhalants.
10/16/2001US6302863 Method for removal of lipids via a perfluorocarbon tumescent solution
10/16/2001US6302838 Cancer treatment with epothilones
10/16/2001US6302837 Benzothiophene, benzofuran and indole compounds
10/16/2001US6302108 Spermicidal and viricidal compositions
10/16/2001CA2241464C Nisin in combination with glycerol monolaurate active against helicobacter
10/16/2001CA2210988C A low phosphorus animal feed containing 1.alpha.-hydroxylated vitamin d compounds
10/16/2001CA2152615C Atovaquone pharmaceutical compositions
10/16/2001CA2098302C Medicaments
10/16/2001CA2089366C Penem compounds
10/16/2001CA2089349C New pyrolidine derivatives, process for their preparation and pharmaceutical composition holding same